The FDA officially approved Ocrelizumab (brand name: Ocrevus) for use in multiple sclerosis treatment on March 28, 2017. In this live Q&A, Dr. Timothy Vollmer answers some common questions on…
Read More
Last night, the FDA approved Ocrelizumab to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). This is the first drug approved by…
The Rocky Mountain MS Center’s MS Young Professionals Network (MSYPN) is starting to grow! The mission of MSYPN is to provide an opportunity for young professionals to support the work…
Social Security has issued important new regulations which will go into effect for applications filed on or after March 27, 2017. These regulations, in most cases, may make it harder…
InforMS: What do we mean by sexual dysfunction and how might multiple sclerosis contribute to it? Pat Kennedy: Sexual dysfunction is a physical change to the way an individual responds…
Jane (not her real name) is a woman who has had MS for nine years and agreed to share her story with us. InforMS: Jane, thank you very much for…
Sexual problems are a common complaint among people with MS. Studies estimate that 40 to 85 percent of women and 50 to 90 percent of men report some type of…
The connection between multiple sclerosis and vitamin D levels is an area of study that has long been of interest to researchers and people who are living with MS. A…
Over the last thirty years, we’ve refined our understanding of MS. With each research study, another dot is added to our picture of the disease. It’s certainly not a straight…